Here's Why You Should Add CW Stock to Your Portfolio Right Now

Zacks ranks Curtiss‑Wright (CW) a #2 (Buy) citing 2025 consensus EPS of $13.09 (+20.1% YoY) and sales of $3.44bn (+10.2%), with a 3–5 year earnings CAGR of 14.5% and an average earnings surprise of 7.75% over the last four quarters. The company’s balance sheet and liquidity look healthy—debt-to-capital 27.7% versus an industry 49.4%, times interest earned 14.92 and a current ratio of 1.75—and shares have outperformed peers, up 9.8% over the past three months. Curtiss‑Wright’s growth outlook is supported by exposure to nuclear new‑build (reactor coolant pumps, AP1000 technologies) and the Ultra Energy acquisition, plus defense tailwinds (submarine funding) and improving commercial aerospace demand, leaving it well‑positioned to capture secular clean‑energy and defense spending while sustaining cash generation and shareholder returns.

Analysis

Curtiss‑Wright is a Zacks Rank #2 (Buy) with a consensus 2025 EPS of $13.09, implying +20.1% year‑over‑year growth, and consensus 2025 sales of $3.44 billion, implying +10.2% growth. Zacks projects a three‑to‑five‑year earnings CAGR of 14.5%, and the company posted an average earnings surprise of 7.75% over the last four quarters.

Balance sheet metrics support the outlook: total debt‑to‑capital is 27.7% versus an industry average of 49.4% and times‑interest‑earned was 14.92 at the end of Q3 2025, indicating strong interest coverage. A current ratio of 1.75 signals adequate short‑term liquidity, and shares have risen 9.8% over the past three months compared with a 3% industry advance.

Growth catalysts include participation in nuclear new‑build projects via reactor coolant pumps and AP1000 technologies, the Ultra Energy acquisition that strengthens reactor protection and monitoring, and demand tailwinds from higher U.S. submarine funding and improving commercial aerospace production. Key near‑term triggers and risks are the realization of AP1000 orders, successful integration and execution of Ultra Energy, and the sustainment of defense and aerospace spending that underpin consensus estimates.

Key Decisions for Investors

• Consider an overweight or accumulation stance on CW relative to aerospace peers given the 20.1% 2025 EPS growth forecast, healthy balance sheet (27.7% debt-to-capital) and recent outperformance, but size positions to risk tolerance
• Monitor AP1000 order flow, Ultra Energy integration progress and quarterly earnings beats (histor average surprise 7.75%) as primary catalysts or red flags that should trigger rebalancing
• Before increasing exposure, compare CW's risk-adjusted upside and valuation versus peers ATRO, HEI and WWD, and employ position limits or hedges if defense funding or order momentum weakens